Stockscreener 앱 받기
27.02
1.28%
-0.3501
전일 마감가:
$27.37
열려 있는:
$26.77
하루 거래량:
903.74K
Relative Volume:
1.01
시가총액:
$1.62B
수익:
$439.00K
순이익/손실:
$-105.64M
주가수익비율:
-15.01
EPS:
-1.8
순현금흐름:
$-60.70M
1주 성능:
-9.21%
1개월 성능:
+12.58%
6개월 성능:
-17.82%
1년 성능:
-51.64%
1일 변동 폭
$26.33
$27.66
1주일 범위
$26.33
$29.88
52주 변동 폭
$21.73
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
명칭
Janux Therapeutics Inc
전화
(858) 751-4493
주소
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
JANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
26.98 | 1.64B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.76 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.97 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.22 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.78 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-10 | 개시 | Stifel | Buy |
| 2025-09-10 | 개시 | Truist | Buy |
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-07-11 | 개시 | Raymond James | Outperform |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-12-03 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-22 | 개시 | Leerink Partners | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-05-30 | 개시 | Scotiabank | Sector Perform |
| 2024-03-21 | 개시 | BTIG Research | Buy |
| 2024-03-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-06 | 개시 | Wedbush | Outperform |
| 2022-11-14 | 개시 | William Blair | Outperform |
모두보기
Janux Therapeutics Inc 주식(JANX)의 최신 뉴스
Volume spikes in Janux Therapeutics Inc. stock – what they meanJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
Why Janux Therapeutics Inc. stock remains undervaluedJuly 2025 Retail & Real-Time Chart Pattern Alerts - newser.com
Is Janux Therapeutics Inc. stock attractive for income investorsJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
Is Restile Ceramics Limited Stock Discounted Enough After Recent DeclinesRSI Overbought/Oversold & Fast Profit Stock Ideas - earlytimes.in
Can Janux Therapeutics Inc. stock surprise with earnings upsideTrade Volume Summary & Weekly Top Gainers Alerts - newser.com
Is Janux Therapeutics Inc. stock a safe buy before earningsWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com
Using fundamentals and technicals on Janux Therapeutics Inc.Quarterly Trade Report & Fast Moving Stock Watchlists - newser.com
What analysts say about Janux Therapeutics Inc stockTechnology Stock Trends & Turn Data into Profits With Our Strategies - earlytimes.in
AlphaQuest LLC Has $224,000 Stock Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat
Will Janux Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Consistent Return Investment Signals - newser.com
Insider Selling: Janux Therapeutics (NASDAQ:JANX) Insider Sells 16,665 Shares of Stock - MarketBeat
Janux Therapeutics Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Janux Therapeutics Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com
Insider Sell: Andrew Meyer Sells Shares of Janux Therapeutics In - GuruFocus
Janux therapeutics CBO Meyer sells $500k in shares By Investing.com - Investing.com Canada
Janux Therapeutics: The Rumor Mill Spins Up Again (NASDAQ:JANX) - Seeking Alpha
Janux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last? - Yahoo Finance
Janux Therapeutics (JANX) Projected to Post Earnings on Wednesday - MarketBeat
Janux Therapeutics (NASDAQ:JANX) Shares Up 8.6%Should You Buy? - MarketBeat
Exclusive BAC Article: Janux Therapeutics; 2nd Half Of 2025 JANX007 mCRPC Results Along With JANX008 In Metastatic Solid Tumors And Catalysts (NASDAQ:JANX) - Seeking Alpha
Is Janux Therapeutics Inc. stock positioned for long term growthJuly 2025 Movers & AI Powered Trade Plan Recommendations - fcp.pa.gov.br
Janux Therapeutics stock gains amid renewed takeover speculation - Seeking Alpha
Can Janux Therapeutics' Upcoming Immunotherapy Updates Drive A Stock Rebound? - RTTNews
Janux Therapeutics Advances with Promising Study on JANX008 for Solid Tumor Treatment - TipRanks
Janux Therapeutics Advances Prostate Cancer Study with JANX007 - TipRanks
Janux Therapeutics Inc (JANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):